Atlas Trials

Chemotherapy for Patients With Osteosarcoma

Clinical trial NCT00523419 · COMPLETED

Trial details

NCT number
NCT00523419
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Osteosarcoma
Start date
2007-09-01
Primary completion
2009-06-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.